Offer An Article

Pandemic Latest News

generic medicines

Generic medicines and the part they play – an interview with Medkart Pharmacy founder Ankur Agarwal

Generic medicines are a core component of India’s reputation as the so-called ‘pharmacy of the world.’ The country has long been-renowned for its exports of affordable medicines to developing nations. As previously reported by Health Issues India, “generic medicines cost a fraction of the monopoly prices charged in countries like the United States, and competition […]

Generic medicines and the part they play – an interview with Medkart Pharmacy founder Ankur Agarwal Read More »

Jan Aushadhi: Government eyes expansion

The Union Government has announced a planned expansion of its Pradhan Mantri Bhartiya Jan Aushadhi Pari Yojana Kendra (PMBJPK) initiative, as Jan Aushadhi Diwas celebrations took place in recent days to celebrate efforts to increase access to medicines for the population.  The scheme’s vision is to reduce out-of-pocket expenditure on healthcare through the provision of

Jan Aushadhi: Government eyes expansion Read More »

Opening Indian pharma’s Bottle of Lies

“They often make their worst drugs — with the lowest-quality ingredients and the most manufacturing shortcuts — for the least regulated markets, including India,” writes investigative journalist Katherine Eban in her book Bottle of Lies: The Inside Story of the Generic Boom (also subtitled as Ranbaxy and the Dark Side of Indian Pharma), an exposé

Opening Indian pharma’s Bottle of Lies Read More »

#HealthForAll: Why India lacks access to healthcare

Here is another example of the crumbling state of India’s healthcare infrastructure and the reason behind lack of access to essential, life-saving drugs. India has a shortage of an estimated 600,000 doctors and two million nurses, claims a study conducted by the Centre for Disease Dynamics, Economics & Policy (CDDEP), titled “Access Barriers to Antibiotics.”

#HealthForAll: Why India lacks access to healthcare Read More »

Pharma fears over Jan Aushadhi

The Centre’s flagship access to medicines scheme may be a boon for patients. However, it is also stoking fears among Indian pharma. Forecasts estimate that drugmakers could see twenty percent of their sales disrupted by the Pradhan Mantri Bhartiya Jan Aushadhi Pari Yojana Kendra (PMBJPK), a health ministry campaign to make medicines more affordable for

Pharma fears over Jan Aushadhi Read More »

Jan Aushadhi Diwas: What the Prime Minister said

Jan Aushadhi Diwas celebrations heralded the Centre’s scheme to expand access to medicines – and included a high-profile speech from Prime Minister Modi, in which he extolled the benefits of the initiative. Beneficiaries of the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) include both the poor and middle-class, the Prime Minister claimed during a video conference

Jan Aushadhi Diwas: What the Prime Minister said Read More »

Jan Aushadhi Diwas: Centre expands plans for access to medicines

The Centre will add 2,500 Jan Aushadhi stores to its existing stock by 2020 – with the eventual aim of one store for every block. Jan Aushadhi stores are special kendras (centres) opened under the Centre’s Pradhan Mantri Bhartiya Jan Aushadhi Pari Yojana Kendra (PMBJPK) initiative, which seeks to expand access to medicines. These  centres

Jan Aushadhi Diwas: Centre expands plans for access to medicines Read More »

Generic medicines: Centre pushes for cheaper drugs

In a bid to make generic medicines more eye-catching, the Central government is planning to introduce an innovative marketing strategy to increase their brand awareness among consumers. New Union Health Ministry plans would colour-code generic medicines to distinguish them from their more costly brand-name counterparts. This is in a bid to encourage consumers to make

Generic medicines: Centre pushes for cheaper drugs Read More »

Indian pharma welcomes EU-US collaboration on testing and inspection

Indian pharmaceutical companies will face tighter scrutiny following an ‘unprecedented’ agreement between US and EU agencies. This does not seem to be worrying industry insiders, however.  The United States Food and Drug Administration (FDA) signed an agreement of mutual recognition with a number of European Union member states in October last year.  This saw the

Indian pharma welcomes EU-US collaboration on testing and inspection Read More »